Log In
BCIQ
Print this Print this
 

Natural killer T cells

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Natural killer T cells

BCIQ
Print ChartPrint this
0 0 1 0 1 0 0 0 0 1 0 0 0 1 0 1 0 0 0 1
Phases of DevelopmentPreclinicalPhase IPhase I/IIPhase II
Autoimmune

0

0

0

1

Cancer

0

1

0

1

Hepatic

0

1

0

0

Inflammation

1

0

0

0

Transplant

0

0

1

0




 Products Targeting Natural killer T cells
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$465.0M

$35.0M

$430.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury Trial today